10,235 Shares in STERIS plc (NYSE:STE) Acquired by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co bought a new stake in shares of STERIS plc (NYSE:STE) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 10,235 shares of the medical equipment provider’s stock, valued at approximately $2,104,000.

A number of other institutional investors and hedge funds have also modified their holdings of STE. Raymond James Financial Inc. purchased a new stake in shares of STERIS during the fourth quarter valued at $223,987,000. Franklin Resources Inc. lifted its stake in STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after acquiring an additional 529,308 shares during the period. Boston Trust Walden Corp boosted its holdings in shares of STERIS by 400.4% during the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock valued at $46,198,000 after acquiring an additional 179,829 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of STERIS by 15.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,261,927 shares of the medical equipment provider’s stock worth $257,585,000 after acquiring an additional 172,795 shares during the period. Finally, Benjamin Edwards Inc. raised its holdings in shares of STERIS by 2,123.2% during the third quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider’s stock valued at $27,574,000 after purchasing an additional 108,559 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Analysts Set New Price Targets

STE has been the topic of several research reports. JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Stephens restated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler upped their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Down 0.6 %

Shares of STE stock opened at $222.99 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock has a market cap of $21.91 billion, a P/E ratio of 47.34 and a beta of 0.92. The company has a 50 day simple moving average of $222.51 and a two-hundred day simple moving average of $221.30.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.